Thursday, 15 October 2026European Markets

ING GROEP N.V., SPBK1 ØSTFOLD AKE, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(vianews) - ing groep n.v. (inga.as) is among this list of stock assets with the highest dividend rate and return on equity on the financial services sector.

financial asset price forward dividend yield return on equity
ing groep n.v. (inga.as) €16.44 6.76% 8.24%
spbk1 østfold ake (soag.ol) kr337.00 6.3% 11.18%
crcam ille-vil.cci (civ.pa) €54.50 4.06% 2.95%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ing groep n.v. (inga.as)

6.76% forward dividend yield and 8.24% return on equity

ing groep n.v. provides various banking products and services in the netherlands, belgium, germany, rest of europe, and internationally. it operates through five segments: retail netherlands, retail belgium, retail germany, retail other, and wholesale banking. the company accepts current and savings accounts. it also offers business lending products; sme loans; consumer lending products, such as residential mortgage loans and other consumer lending loans; and mortgages. in addition, the company provides working capital solutions; debt and equity market solutions; various loans; payments; and cash management, trade and corporate finance, and treasury services, as well as savings, investment, insurance, and digital banking services. it serves individual customers, corporate clients, and financial institutions. ing groep n.v. was founded in 1762 and is headquartered in amsterdam, the netherlands.

earnings per share

as for profitability, ing groep n.v. has a trailing twelve months eps of €2.08.

pe ratio

ing groep n.v. has a trailing twelve months price to earnings ratio of 7.9. meaning, the purchaser of the share is investing €7.9 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.24%.

more news about ing groep n.v..

2. spbk1 østfold ake (soag.ol)

6.3% forward dividend yield and 11.18% return on equity

sparebank 1 østfold akershus, a savings bank, provides various banking products and services. the company offers savings, operating, tax deduction, deposit, placement, and currency accounts; and savings and investment products. it also provides consumer, construction, repayment, boat, motorcycle, and car loans; operating credit products; bank guarantees; operating credit for agriculture; mortgage products; leasing and factoring services. in addition, the company offers various insurance products, such as vehicle, house and travel, personal, animal, liability, work machine, interruption, condominium, cyber, movable property, commercial building, project, transport, crime, bus, group life, health, leisure accident, occupational injury, accident insurance children, and sick pay insurance products; and pension products. further, it provides credit, municipal payment, and other bank cards; payment terminal, debt collection, and document collection services; bonds, forwards, and currency options; invoice automatic, egiro/cremul, kid invoice, and ocr and egiro payment services; and mobile and online banking services. sparebank 1 østfold akershus was founded in 1835 and is headquartered in moss, norway.

earnings per share

as for profitability, spbk1 østfold ake has a trailing twelve months eps of kr39.02.

pe ratio

spbk1 østfold ake has a trailing twelve months price to earnings ratio of 8.64. meaning, the purchaser of the share is investing kr8.64 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.18%.

revenue growth

year-on-year quarterly revenue growth declined by 12.1%, now sitting on 1.12b for the twelve trailing months.

more news about spbk1 østfold ake.

3. crcam ille-vil.cci (civ.pa)

4.06% forward dividend yield and 2.95% return on equity

caisse régionale de crédit agricole mutuel d'ille-et-vilaine société coopérative provides banking services in france. it offers bank accounts and related services; bank cards; saving solutions; real estate investment solutions; insurance products, such as car and two-wheeler, personal, health and welfare, home, and borrower insurance, as well as life insurance products; real estate loans; and consumer credit comprising personal, auto, green vehicle, work, boating, student, and apprentice loans, as well as renewable credit. the company was founded in 1900 and is based in saint-jacques-de-la-lande, france. caisse régionale de crédit agricole mutuel d'ille-et-vilaine société coopérative operates as a subsidiary of crédit agricole s.a.

earnings per share

as for profitability, crcam ille-vil.cci has a trailing twelve months eps of €10.49.

pe ratio

crcam ille-vil.cci has a trailing twelve months price to earnings ratio of 5.2. meaning, the purchaser of the share is investing €5.2 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.95%.

yearly top and bottom value

crcam ille-vil.cci's stock is valued at €54.50 at 12:30 est, way under its 52-week high of €70.40 and above its 52-week low of €52.50.

volatility

crcam ille-vil.cci's last week, last month's, and last quarter's current intraday variation average was 1.06%, 0.18%, and 1.16%.

crcam ille-vil.cci's highest amplitude of average volatility was 1.06% (last week), 1.49% (last month), and 1.16% (last quarter).

more news about crcam ille-vil.cci.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com